US2020040067A1PendingUtilityA1
Anti-salmonella antibodies and uses thereof
Est. expiryFeb 4, 2035(~8.5 yrs left)· nominal 20-yr term from priority
A61P 31/04A61P 43/00G01N 33/56916C07K 2317/22A61K 35/66C07K 2317/76C12N 7/00C07K 2317/569C07K 16/1235C07K 2317/565A61K 39/40C07K 16/005A61K 45/06C07K 2317/94Y02A50/30
32
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides anti-Salmonella antibodies or antibody fragments such as camelid single domain antibodies (VHHs), along with associated nucleic acids, host cells and phages. Methods of reducing the presence of Salmonella in an animal or an animal environment, methods and formulations for treating Salmonella infection, and methods of detecting Salmonella are also described.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated antibody or antibody fragment that binds to Salmonella comprising a Complementary Determining Region (CDR)1, a CDR2 and a CDR3, wherein the CDR1, CDR2 and CDR3 comprise the following:
(i) the CDR1 comprising an amino acid sequence of GLDFSSYA (SEQ ID NO:40), (ii) the CDR2 comprising an amino acid sequence of ISRFGGRL (SEQ ID NO:41), and (iii) the CDR3 comprising an amino acid sequence of AADRRSGLGTSKEYDY (SEQ ID NO:42).Join the waitlist — get patent alerts
Track US2020040067A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.